Corline Biomedical
9.4
SEK
0 %
Less than 1K followers
CLBIO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
0%
-16.07%
+7.06%
+18.99%
+16.05%
-29.32%
-27.41%
-25.35%
-4.97%
Corline Biomedical is active in the pharmaceutical industry. The company works with the substance heparin and has developed a portfolio of drug candidates for use in connection with organ and cell transplantation. The company sells its proprietary product CHS™ to medical technology customers, and is developing Renaparin® for use in regenerative medicine and organ transplantation. The headquarters are located in Uppsala.
Read moreMarket cap
230.21M SEK
Turnover
20.47K SEK
Revenue
9.78M
EBIT %
-236.91 %
P/E
-
Dividend yield-%
-
Financial calendar
8.5
2025
Interim report Q1'25
15.5
2025
General meeting '25
26.8
2025
Interim report Q2'25
All
Press releases
ShowingAll content types
Redeye: Redeye Initiates Coverage of Corline Biomedical
Corline Biomedical AB: Will present at investor event hosted by Aktiespararna on June 3rd in Stockholm
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools